Publications by authors named "C Cirkel"
Study Question: Is there a difference in the use of endocrine endometriosis therapy in endometriosis patients with and without endometrioma?
Summary Answer: Patients with endometriomas received significantly less endocrine endometriosis treatment (present intake in 42.5%) compared to patients with other forms of endometriosis and without endometriomas (present intake in 52.1%).
Endometriosis Patients Have an Increased Risk of Experiencing Long-Covid Symptoms: Results from a Cross-Sectional Multicenter Study.
Womens Health Rep (New Rochelle)
September 2024
Article Synopsis
- - Women with a history of menstrual pain or endometriosis are at a higher risk of developing long COVID-19 symptoms, with this study focusing on 840 premenopausal participants, most of whom had contracted COVID-19.
- - Among those studied, 312 had acute COVID-19, while significant percentages developed postacute or long COVID symptoms, with surgically confirmed endometriosis patients showing a twofold increased risk for long COVID compared to those without confirmed endometriosis.
- - Additional factors like anxiety and depression further doubled the risk of long COVID in women with endometriosis, indicating a need for further research into how treating these mental health issues might reduce long COVID occurrences among these patients.
De-escalation is currently taking place in both the surgical and systemic treatment of breast cancer. The introduction of trastuzumab, the first monoclonal antibody against the HER2 receptor, over 20 years ago was a milestone in the treatment of HER2-positive breast cancer and marked the beginning of a new era in targeted tumor therapy. In the sense of de-escalation, omitting non-targeted cytotoxic chemotherapy altogether is often hailed as the ultimate goal of oncological research.
View Article and Find Full Text PDFBackground: Anti-NMDA-receptor (anti-NMDAR) encephalitis is often associated with ovarian teratoma (OT). The best management of anti-NMDAR encephalitis patients with normal imaging studies (pelvic ultrasound/MRI) but clinically high risk of OT (e.g.
View Article and Find Full Text PDFBackground: Recently, antibodies against the alpha isoform of the glial-fibrillary-acidic-protein (GFAPα) were identified in a small series of patients with encephalomyelitis. Coexisting autoantibodies (NMDA receptor, GAD65 antibodies) have been described in a few of these patients. We describe a patient with rapidly progressive encephalomyeloradiculitis and a combination of anti-ITPR1, anti-GFAP and anti-MOG antibodies.
View Article and Find Full Text PDF